StockTipsArenaBeta

BUY Lupin Limited — BOB Capital Markets

BUYLupin Limited

byBOB Capital MarketsHorizon: NA (inferred 1 year)7 Aug 2025via Institutional / Brokerage Research

Entry₹1,944.2Inferred
Target₹2,626
Total upside +35.07% (call closed)
Stop lossNot given
At expiry₹2,363.57 Aug 2026, 3:30 pm
Expired+21.57%auction close
Follow BOB Capital Markets for new calls(63% target hit, 356 closed calls)Get alertsWatch LUPIN for new buy/sell callsGet alertsSee 14 active Long-term calls on LUPINSee 40 active Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 7 Aug 2026
35 supporting2 neutral8 opposing
Supports the BUY call (35)

Lupin Q1 results driven by strong US sales; stock slips from day's high

NewsCnbc-Tv18·7 Aug · today

(opens in new tab)

Lupin Shares Rise After Q1 Profit, Revenue Beat Street Estimates

NewsNdtv-Profit·7 Aug · today

(opens in new tab)

After Crushing Q1 Estimates, What's Next For Lupin? Macquarie Makes Its Case

NewsNdtv-Profit·7 Aug · today

(opens in new tab)

Lupin Q1 results driven by strong US sales; stock in focus

NewsCnbc-Tv18·7 Aug · today

(opens in new tab)

Q1 Results Updates: Lupin Profit Rises 16%, Britannia Revenue Hits Rs 5,000 Crore

NewsNdtv-Profit·6 Aug · today

(opens in new tab)
Neutral / worth noting (2)

Lupin Limited has set July 17, 2026, as the record date for dividend purposes.

NSE · Record Date·8 Jul · 4w ago

(opens in new tab)
Weighs against the BUY call (8)

US tariff threat drags Nifty Pharma 1.3% lower at close; Lupin, PPL Pharma lead decline

NewsHbl·22 Jul · 2w ago

(opens in new tab)

Top Gainers & Losers on 22 July: Bandhan Bank, PG Electroplast, Lupin, Delhivery, Voltas, IndiGo among top losers

NewsLivemint·22 Jul · 2w ago

(opens in new tab)

US tariff threat drags Nifty Pharma 1.4% lower; Lupin, Auropharma lead decline

NewsHbl·22 Jul · 2w ago

(opens in new tab)

Gland Pharma, Lupin, Dr Reddy's: All Nifty Pharma Stocks In Red After Trump's Drug Tariff Plan

NewsNdtv-Profit·22 Jul · 2w ago

(opens in new tab)

Lupin, Sun Pharma to Cipla: Pharma stocks decline after Trump’s tariffs plan on generic medicines import

NewsLivemint·22 Jul · 2w ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.